Richard Hague

Director at Remedium Bio.

Raised on Remedium Bio filings

$1.5M

of $10M offered across 1 Form D filing

Form D filings: 1
Teammates: 4
Last filing: May 18, 2026

Company

Biotech · Needham, MA

Dose-adjustable gene therapy for obesity and osteoarthritis

Dose-adjustable gene therapy for obesity and osteoarthritis

Investors: 1
Still open: $8.5M

Investors: 1
Sector: Biotech
HQ: Needham, MA

Remedium Bio filings

Remedium Bio Form D filings
Filed	Security	Sold of offered	Filing
May 18, 2026	Equity	$1.5M/ $10M	Form D

EquityFiled May 18, 2026Form D
$1.5M/ $10M

Works with

Also named on Remedium Bio filings

Gerard P O'ConnorAssistant Secretary, Form D signerForm D signer Harry RobbDirector Alexei GoraltchoukExecutive Officer, Director Frank LuppinoExecutive Officer, Director